Croda International Plc ('Croda') today confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.

Attachments

  • Original document
  • Permalink

Disclaimer

Croda International plc published this content on 12 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 August 2020 07:57:14 UTC